LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 59.85 | 27.76 | 8311 | 6062 | 1.3709 | 1.0829 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 59.85 | 27.76 | 1147 | 6062 | 0.1892 | 0.6143 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 59.85 | 27.76 | 8261 | 6062 | 1.3626 | 1.0812 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 61.56 | 27.76 | 538 | 6217 | 0.0865 | 0.4618 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 61.56 | 27.76 | 8754 | 6217 | 1.4080 | 1.0896 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 61.56 | 27.76 | 1144 | 6217 | 0.1840 | 0.6101 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 61.56 | 27.76 | 8638 | 6217 | 1.3894 | 1.0860 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 63.26 | 27.76 | 572 | 6465 | 0.0885 | 0.4693 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 63.26 | 27.76 | 9220 | 6465 | 1.4260 | 1.0923 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 63.26 | 27.76 | 1138 | 6465 | 0.1760 | 0.6036 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 63.26 | 27.76 | 9132 | 6465 | 1.4124 | 1.0898 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 64.97 | 27.76 | 756 | 6656 | 0.1136 | 0.5189 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 64.97 | 27.76 | 9616 | 6656 | 1.4445 | 1.0952 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 64.97 | 27.76 | 1087 | 6656 | 0.1633 | 0.5903 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 64.97 | 27.76 | 9456 | 6656 | 1.4205 | 1.0908 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 66.67 | 27.76 | 816 | 6695 | 0.1219 | 0.5330 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 66.67 | 27.76 | 9983 | 6695 | 1.4910 | 1.1035 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 66.67 | 27.76 | 1148 | 6695 | 0.1715 | 0.6005 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 66.67 | 27.76 | 9780 | 6695 | 1.4606 | 1.0981 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 68.37 | 27.76 | 735 | 6879 | 0.1068 | 0.5098 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 68.37 | 27.76 | 10255 | 6879 | 1.4907 | 1.1030 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 68.37 | 27.76 | 1154 | 6879 | 0.1678 | 0.5979 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 68.37 | 27.76 | 10056 | 6879 | 1.4618 | 1.0978 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 70.08 | 27.76 | 719 | 6849 | 0.1050 | 0.5061 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 70.08 | 27.76 | 10581 | 6849 | 1.5447 | 1.1125 | MN20160318_Q01 | J13 |